SER serina Therapeutics announces completion of enrollment and dosing in cohort 1 of registrational trial of ser-252 for advanced parkinson’

SER serina Therapeutics announces completion of enrollment and dosing in cohort 1 of registrational trial of ser-252 for advanced parkinson’s disease